Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity
The update reports on a completed study investigating interleukin-6 in plaque psoriasis and its potential link to disease severity.
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis [Phase 2]
This document reports the completion of a Phase 2 trial evaluating JNJ-77242113 for moderate-to-severe plaque psoriasis. The snippet does no…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 study comparing SB17, a proposed ustekinumab biosimilar, to Stelara in adults with moderate-to-severe plaque psoriasis; results have…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis [Phase 2]
This update covers a Phase II study of AC-201 tablets in subjects with plaque psoriasis, which has completed. The document notes the trial s…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms [Phase 3]
This clinical trial update reports the completion of a Phase 3 study of subcutaneous risankizumab in pediatric participants with moderate-to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
A Phase IV clinical trial is evaluating the efficacy and safety of vunakizumab for adults with moderate-to-severe plaque psoriasis and is cu…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study
This completed observational real-world evidence study assesses patient-reported wellbeing with tildrakizumab in plaque psoriasis. The POSIT…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase III trial of SYHX1901 tablets for moderate to severe plaque psoriasis has not yet begun recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients [Phase 3]
A Phase 3 trial comparing BAT2306 with Cosentyx for plaque psoriasis has completed, with the update focusing on efficacy and safety outcomes…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 study evaluating DC-806 in moderate-to-severe plaque psoriasis has completed, and results were posted on 2025-04-04.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants [Phase 3]
A Phase 3 pediatric study evaluating the efficacy, safety, and pharmacokinetics of subcutaneously administered guselkumab for chronic plaque…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
This Phase 2 trial update assesses the pharmacokinetics, safety, and efficacy of two doses of bimekizumab in adolescents with moderate to se…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis [Phase 3]
A Phase 3 trial in adult Chinese subjects with stable plaque psoriasis compared LEO 90100 to Daivobet ointment to evaluate efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis [Phase 2]
Clinical trial update reporting the results of a Phase 2 study evaluating safety, tolerability, and efficacy in subjects with plaque psorias…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]
A Phase 3 study evaluating a recombinant anti-IL-17A humanized monoclonal antibody in Chinese patients with moderate-to-severe plaque psoria…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis [Phase 1]
A Phase 1 study evaluating AK111 for moderate-to-severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 1, Phase 2]
The AK101 study in moderate to severe plaque psoriasis has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial of ICP-488 in moderate-to-severe plaque psoriasis has completed, reporting efficacy, safety, pharmacokinetics and pharmacodyna…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Akeso reports that the Phase 2 clinical study of AK101 in moderate to severe plaque psoriasis has completed. The summary does not provide ef…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating AK111 for moderate to severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis [Phase 2]
A Phase 2 clinical trial update reports the completion of a Phase 2 study evaluating jaktinib in participants with plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis [Phase 1]
This update notes the completion of a Phase 1 study of S011806 (DC-806 or LY4100504) in healthy adults and participants with chronic plaque …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial update for AK111 injection in moderate-to-severe plaque psoriasis; the study has completed, but efficacy and safety results ar…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis [Phase 2]
Phase 2 study of KBL697 in adults with moderate plaque psoriasis has completed, with efficacy and safety results to be reported.
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis [Phase 3]
An open-label extension trial of roflumilast (PDE4 inhibitor) for chronic plaque psoriasis has completed Phase 3 testing, focusing on long-t…